ClinPhone – the world leader in telephone and Internet-based Electronic Trial Management solutions – has hired former Healthcare Technology Systems (HTS) Vice President, Keith Wenzel, to optimize the use of licensed HTS clinical assessments within clinical trials.

ClinPhone recently secured an exclusive, worldwide perpetual license for the use of HTS’ assessments on any device or medium used in Phase I - IV clinical trials funded by pharmaceutical, biotechnology or medical device companies. “We are delighted to bring Keith on board. He is a noted expert in the use of technology to collect patient reported outcomes,” said Howard Goldberg, Vice President and General Manager of ClinPhone Inc. “Keith brings our clients over 15 years of industry experience as well as extensive knowledge in validating computer-administered clinical assessments and designing information systems that emphasize efficiencies.”

Wenzel will be based at the company’s Chicago office. His initial assignment as Project Consultant - Patient Rated Assessments will be to help ClinPhone build on the expertise it already has within the electronic patient reported outcomes arena. He will act as an information resource for operations staff and for business development managers ensuring a smooth transition from sale through project delivery. He will also interface directly with existing and potential customers to provide information and expertise on the use of the patient rated assessments.

“I have enjoyed working with ClinPhone as a partner over the past few years and I am happy to be working even more closely with my colleagues,” Wenzel commented. "My new role will build on my experience with HTS and will include client consultation for electronic patient assessments and liaison with HTS physicians for the licensed assessments," he explained.

ClinPhone is the most experienced clinical technology provider in the pharmaceutical industry. It counts the vast majority of pharma and biotech companies as clients including preferred supplier agreements with 15 of the top 20 pharmaceutical companies. The company has supported over 1000 clinical trials (of which more than 300 are currently active) in over 80 countries and almost 70 languages. Finally, its system is the most robust and advanced in the industry handling up to 90,000 calls per month.

ends

For further information, please contact:

Richard Gee +44 115 9508399 This email address is being protected from spambots. You need JavaScript enabled to view it.
Sally Kent +44 115 9557333 This email address is being protected from spambots. You need JavaScript enabled to view it.
Daja Herald +1 609 524 4100 This email address is being protected from spambots. You need JavaScript enabled to view it.


THIS RELEASE HAS BEEN DISTRIBUTED BY WEBITPR (www.webitpr.com)

Disclaimer:

Whilst WebitPR Ltd endeavour to ensure the accuracy of the information contained in this Release, WebitPR Ltd cannot accept any liability for:-

• the inaccuracy or otherwise of any information contained in this Release; or
• any loss liability or expense which may be suffered by any party in consequence of acting or omitting to act as a result of any information contained in or omitted from this Release; or
• any loss or suffering which may be caused by or to any party either as a result of the information contained in this Release or such information contained in this Release being inaccurate or otherwise misleading.

In the event that any information contained in this Release is inaccurate or misleading then please contact WebitPR at the above e-mail address.